Glucose-Regulating Drugs Aid COVID-19 Outcomes in Patients With Diabetes
Findings include GLP-1R agonists and pioglitazone use, with drop in hospital admissions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.